News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Manar: Budget Unlikely by May 31

Fresh
state_capitol_4

"Cutting vital services, banking $2.2 billion of... just... fictional pension savings that aren't going to occur, we're going to claim to be balanced?"

in Local

Illinois Bill Penalizes for Leaving Pets in Extreme Weather

cat

Offenders could face up to a year in jail and fines of up to $2,500.

in Local

Mt. Zion High School to Randomly Drug Test Some Students

Updated
drugtest

Students will be randomly selected for urinalysis tests to detect alcohol or marijuana, among other drugs.

in Local

Measure Banning Electronic Cigarettes for Minors Passes Legislature

HEALTHY SMOKING

Vaping's not for kids. At least, that's what Illinois lawmakers say.

in Local

Lawmakers Could Consider “Turnaround Agenda” Items Wednesday

Illinois Gov. Bruce Rauner delivers his inauguration address Monday, Jan. 12, 2015, in Springfield, Ill., after being sworn in as Illinois' 42nd governor.

Proposals addressing workers compensation, changes to the civil legal system and a freeze on properties taxes are on the agenda today in Senate committees.